0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Ophthalmology | 
Original Investigation | 
Writing Team for the DCCT/EDIC Research Group
JAMA Ophthalmol. 2016;134(2):137-145. doi:10.1001/jamaophthalmol.2015.4606.
Includes: CME, Supplemental Content

JAMA Ophthalmology | 
Original Investigation | 
Neil M. Bressler, MD; Rohit Varma, MD; Paul Mitchell, MD; et al.
JAMA Ophthalmol. 2016;134(2):160-166. doi:10.1001/jamaophthalmol.2015.4636.
Includes: Supplemental Content

JAMA Ophthalmology | 
Invited Commentary | 
Emily Y. Chew, MD
JAMA Ophthalmol. 2016;134(2):135-136. doi:10.1001/jamaophthalmol.2015.4652.

JAMA Ophthalmology | 
Original Investigation | 
John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.
JAMA Ophthalmol. 2016;134(2):127-134. doi:10.1001/jamaophthalmol.2015.4599.
Includes: Supplemental Content

JAMA Ophthalmology | 
Invited Commentary | 
Jennifer K. Sun, MD, MPH; Jerry D. Cavallerano, OD, PhD; Paolo S. Silva, MD
JAMA Ophthalmol. 2016;134(2):210-211. doi:10.1001/jamaophthalmol.2015.5099.

JAMA Ophthalmology | 
Original Investigation | 
O. Bennett Walton IV, MD, MBA; Robert B. Garoon, MD; Christina Y. Weng, MD, MBA; et al.
JAMA Ophthalmol. 2016;134(2):204-209. doi:10.1001/jamaophthalmol.2015.5083.

JAMA Ophthalmology | 
Original Investigation | 
Yu T. Wang, BS; Mongkol Tadarati, MD; Yulia Wolfson, MD; et al.
JAMA Ophthalmol. 2016;134(2):222-228. doi:10.1001/jamaophthalmol.2015.5332.
Includes: Supplemental Content

JAMA Ophthalmology | 
Invited Commentary |  ONLINE FIRST
Gabriel Coscas, MD; Marco Lupidi, MD; Florence Coscas, MD
JAMA Ophthalmol. Published online January 21, 2016. doi:10.1001/jamaophthalmol.2015.4821

JAMA Ophthalmology | 
Original Investigation |  ONLINE FIRST
Thomas S. Hwang, MD; Simon S. Gao, PhD; Liang Liu, MD; et al.
JAMA Ophthalmol. Published online January 21, 2016. doi:10.1001/jamaophthalmol.2015.5658
Includes: Supplemental Content

JAMA Ophthalmology | 
Invited Commentary |  ONLINE FIRST
Rajendra S. Apte, MD, PhD
JAMA Ophthalmol. Published online January 07, 2016. doi:10.1001/jamaophthalmol.2015.5469

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Original Investigation  | 
Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort
Writing Team for the DCCT/EDIC Research Group
JAMA Ophthalmology
Original Investigation  | 
Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema Report From RESTORE, RIDE, and RISE Trials
Neil M. Bressler, MD; Rohit Varma, MD; Paul Mitchell, MD; et al.
JAMA Ophthalmology
Invited Commentary  | 
Drilling Deeper for Treatment Choices in Diabetic Macular Edema
Emily Y. Chew, MD
JAMA Ophthalmology
Original Investigation  | 
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.